Global Calcium is one of the leading manufacturers and exporters of
Deferasirox CAS no. 201530-41-8, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.
As manufacturer of Deferasirox we hereby state the following facts about the drug:
Deferasirox is an oral iron chelator effective for reduction of body iron in iron-overloaded (transfusional hemosiderosis) and non-transfusion-dependent thalassemia, in patients with 2 years of age and older with a well-established safety profile.
Two molecules of deferasirox are capable of binding to 1 atom of iron. Deferasirox works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming a stable complex which is eliminated via the kidneys.
Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market